HAARVI: Hospitalized or Ambulatory Adults with Respiratory Viral Infections

 Beginning in 2016, the Chu Lab has been collecting blood and nasal swab samples of adult inpatients at Harborview Medical Center in Seattle to study acute RSV and influenza infections. The data collected was being used to characterize clinical symptoms of flu vs. RSV and profile antibodies of both pathogens. Since the COVID-19 pandemic this study has pivoted to focus on SARS-CoV-2 with over 300 people in the Seattle area enrolled into a longitudinal cohort study with multiple arms of sample and data collection over the next 2 years. The Chu lab is using these samples to study the clinical outcomes, immune response and viral kinetics over time of individuals infected with SARS-CoV-2 and collaborate with multiple other labs and institutes to do these studies. Collaborators include researchers at the NIH, Fred Hutchinson Cancer Research Center, Vanderbilt University and the Ragon Institute.